BSE filing, NSE: INDGN. Summary written from the filing by ALFA Finder's alert engine.
Indegene Ltd: key numbers
- Share price
- ₹594.70
- Market cap
- ₹14,328 Cr
- Revenue (annual)
- ₹3,510 Cr
- Net profit (annual)
- ₹401.1 Cr
- P/E (TTM)
- 35.7×Sector 52.0×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 12.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indegene Ltd
All →Indegene Merger & Restructuring
Indegene Ltd disclosed that its step-down wholly owned subsidiary, Indegene Portugal Unipessoal LDA, was incorporated on 23 October 2026. The entity has nil turnover and is yet to begin operations.
Indegene Business Update
Indegene received Frost & Sullivan's 2026 Global Enabling Technology Leadership award for AI-powered pharma commercialization. The recognition highlights its domain-led AI platform and workflow transformation capabilities.
Indegene Other Announcement
Indegene Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing details share distribution across promoter and public shareholder categories.
Indegene Management Change
Indegene's Non-Executive Director Mr. Mark Dzialga resigned effective October 29, 2026, following Brighton Park Capital's sale of its entire stake. No other material board changes are disclosed.
Indegene Employee Stock Options
Indegene Limited has allotted 16,110 equity shares under its ESOP Scheme 2020. The board also approved an amendment to the company's POSH policy.
Indegene Business Update
Indegene held its 2026 Digital Summit in Philadelphia, drawing 120+ pharma leaders and 19 speakers. The event showcased the company's AI-native pharma enablement capabilities.
Other board meeting date announcements
All →VJTF Eduservices Board Meeting Date
VJTF Eduservices intimated a board meeting on 6 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The notice is a prior intimation with agenda only proposed.
Utkarsh Small Finance Bank Board Meeting Date
Utkarsh Small Finance Bank gave intimation of a board meeting on November 3, 2026 to consider Q2 and H1 unaudited results. The trading window reopens November 6, 2026.
Gala Global Products Board Meeting Date
Gala Global Products has given advance notice of a board meeting on 3 November 2026 to consider unaudited standalone results for the quarter ended 30 September 2026. The trading window is closed from 1 October 2026 until 48 hours after the results are made public.
Suncity Synthetics Board Meeting Date
Suncity Synthetics Limited has given advance notice of a board meeting on 3 November 2026 to consider its unaudited standalone results for the quarter ended September 30, 2026. No financial figures are disclosed in this intimation.
Ambar Protein Industries Board Meeting Date
Ambar Protein will hold a board meeting on November 5, 2026 to consider quarterly results. Trading window closes for insiders until 48 hours after results.
Mangalam Drugs and Organics Board Meeting Date
Mangalam Drugs will hold a board meeting on 5 November 2026 to consider unaudited September 2026 quarter results. The agenda is proposed only, pending the meeting.